Quantcast
Environmental News for a Healthier Planet and Life

Help Support EcoWatch

Enbridge, TransCanada Play Dirty to Get Tar Sands Oil Across U.S. Border

Energy

In a narrow victory for common sense, yesterday the Senate rejected an attempt to legislate approval of the Keystone XL tar sands pipeline. Senators like California's Barbara Boxer, Hawaii's Brian Schatz and Virginia's Tim Kaine stood up as environmental champions and deserve our thanks for their leadership. But since the beginning, the decision on the pipeline has belonged to President Obama, so there's no good reason for the Senate to have wasted time on trying to circumvent the approval process.

More than 12,000 people showed up to circle the White House on Nov. 6, 2011 in a call to President Obama to reject the proposed Keystone XL tar sands pipeline. Photo credit: Sierra Club

The bigger issue, though, is that there's no good reason to support Canadian tar sands expansion, much less allow more dirty tar sands oil into our country. Even though everything about tar sands oil is destructive, dirty and dangerous, oil companies (and their champions on the Hill) are determined to bring as much of it as they can across our border, even if it means bending, breaking or changing the rules. TransCanada failed this week to get the Senate to do an end run, but another tar sands company, Enbridge, has been having more success in a different branch of government.

Enbridge somehow has convinced the State Department to approve its Keystone XL-sized tar sands pipeline expansion. That's right, this is the same company responsible for the largest onshore oil spill in U.S. history, which contaminated 35 miles of Michigan waterways and wetlands in 2010 with diluted bitumen from tar sands. If Enbridge's expansion of its Alberta Clipper pipeline goes through, the increase in tar sands exports will be equivalent to building 20 new coal-fired power plants.

How did this happen? Enbridge had applied to the State Department to expand the Alberta Clipper back in 2012, which was necessary because, like Keystone XL, the pipe would cross our border with Canada. Since then, the State Department has been going through the environmental review process required by law before making a decision. But Enbridge got tired of waiting. Tar sands producers aren't in it for the long haul—they're eager to cash in while their extreme oil is still economically viable.

So in June, Enbridge sent a letter to the State Department informing it that it had decided to immediately move forward with the Alberta Clipper expansion without waiting for the State Department to complete its review. It would do an end run around the law by diverting the flow of tar sands oil to an adjacent, 1960s-era pipeline called "Line 3" just before it reaches the international border, and then back to Alberta Clipper once it was across the border. Enbridge asserted that the State Department's jurisdiction was limited to the actual border crossing, so the State Department could do nothing to stop it.

Give them points for chutzpah. But, in fact, the State Department has jurisdiction over the entire border, including Line 3. Both pipelines operate under the permission of the State Department. The permits for both pipelines prohibit these kinds of operational changes, and the State Department has the authority to revoke or terminate either permit at any time. Not surprisingly, Enbridge also ignored that the State Department's job is to evaluate whether increased tar sands oil imports into the U.S. are in our national interest, including climate impacts. Just last week, the White House reaffirmed that it is "firmly committed" to that process, which is why we expect President Obama to veto any future legislative attempts to shove Keystone XL down our throats.

Not everyone in his administration, though, seems to have gotten that message, because in July the State Department replied to Enbridge's blatant attempt to avoid the Alberta Clipper permitting process by agreeing that the expansion could go forward.

Maybe we shouldn't be surprised. After all, this is not the first time that the State Department's ties to the oil industry have raised eyebrows. Twice it has ignored its own conflict-of-interest procedures and come under fire for hiring oil-industry groups to write the environmental impact statements for Keystone XL. The resulting reports naturally downplayed Keystone XL's negative impacts despite overwhelming evidence to the contrary. In this case, it appears that the State Department privately met with Enbridge to discuss this new scheme as far back as June 3, yet nothing was disclosed to the public until almost three months later. In addition, the State Department has refused to disclose crucial permitting documents despite Sierra Club requests under the Freedom of Information Act.

That's why the Sierra Club, together with a coalition of environmental and tribal allies, has filed a lawsuit challenging Enbridge's illegal scheme to nearly double the amount of tar sands coming across our border, while avoiding public review and the presidential permit process.

Once again, though, it's important to remember that the stakes extend far beyond the approval of any single pipeline—whether it's proposed by Enbridge or TransCanada. We should be looking for ways to avoid—not encourage—extreme oil sources.

YOU MIGHT ALSO LIKE

Carbon Fee Bill Introduced in the Senate

Protect Children from Chinese Chicken Imports

Stunning NASA Video Illustrates a Year’s Worth of Global Carbon Emissions

EcoWatch Daily Newsletter

Guillain-Barre syndrome occurs when the body's own immune system attacks and injures the nerves outside of the spinal cord or brain – the peripheral nervous system. Niq Steele / Getty Images

By Sherry H-Y. Chou, Aarti Sarwal and Neha S. Dangayach

The patient in the case report (let's call him Tom) was 54 and in good health. For two days in May, he felt unwell and was too weak to get out of bed. When his family finally brought him to the hospital, doctors found that he had a fever and signs of a severe infection, or sepsis. He tested positive for SARS-CoV-2, the virus that causes COVID-19 infection. In addition to symptoms of COVID-19, he was also too weak to move his legs.

When a neurologist examined him, Tom was diagnosed with Guillain-Barre Syndrome, an autoimmune disease that causes abnormal sensation and weakness due to delays in sending signals through the nerves. Usually reversible, in severe cases it can cause prolonged paralysis involving breathing muscles, require ventilator support and sometimes leave permanent neurological deficits. Early recognition by expert neurologists is key to proper treatment.

We are neurologists specializing in intensive care and leading studies related to neurological complications from COVID-19. Given the occurrence of Guillain-Barre Syndrome in prior pandemics with other corona viruses like SARS and MERS, we are investigating a possible link between Guillain-Barre Syndrome and COVID-19 and tracking published reports to see if there is any link between Guillain-Barre Syndrome and COVID-19.

Some patients may not seek timely medical care for neurological symptoms like prolonged headache, vision loss and new muscle weakness due to fear of getting exposed to virus in the emergency setting. People need to know that medical facilities have taken full precautions to protect patients. Seeking timely medical evaluation for neurological symptoms can help treat many of these diseases.

What Is Guillain-Barre Syndrome?

Guillain-Barre syndrome occurs when the body's own immune system attacks and injures the nerves outside of the spinal cord or brain – the peripheral nervous system. Most commonly, the injury involves the protective sheath, or myelin, that wraps nerves and is essential to nerve function.

Without the myelin sheath, signals that go through a nerve are slowed or lost, which causes the nerve to malfunction.

To diagnose Guillain-Barre Syndrome, neurologists perform a detailed neurological exam. Due to the nerve injury, patients often may have loss of reflexes on examination. Doctors often need to perform a lumbar puncture, otherwise known as spinal tap, to sample spinal fluid and look for signs of inflammation and abnormal antibodies.

Studies have shown that giving patients an infusion of antibodies derived from donated blood or plasma exchange – a process that cleans patients' blood of harmful antibodies - can speed up recovery. A very small subset of patients may need these therapies long-term.

The majority of Guillain-Barre Syndrome patients improve within a few weeks and eventually can make a full recovery. However, some patients with Guillain-Barre Syndrome have lingering symptoms including weakness and abnormal sensations in arms and/or legs; rarely patients may be bedridden or disabled long-term.

Guillain-Barre Syndrome and Pandemics

As the COVID-19 pandemic sweeps across the globe, many neurologic specialists have been on the lookout for potentially serious nervous system complications such as Guillain-Barre Syndrome.

Though Guillain-Barre Syndrome is rare, it is well known to emerge following bacterial infections, such as Campylobacter jejuni, a common cause of food poisoning, and a multitude of viral infections including the flu virus, Zika virus and other coronaviruses.

Studies showed an increase in Guillain-Barre Syndrome cases following the 2009 H1N1 flu pandemic, suggesting a possible connection. The presumed cause for this link is that the body's own immune response to fight the infection turns on itself and attacks the peripheral nerves. This is called an "autoimmune" condition. When a pandemic affects as many people as our current COVID-19 crisis, even a rare complication can become a significant public health problem. That is especially true for one that causes neurological dysfunction where the recovery takes a long time and may be incomplete.

The first reports of Guillain-Barre Syndrome in COVID-19 pandemic originated from Italy, Spain and China, where the pandemic surged before the U.S. crisis.

Though there is clear clinical suspicion that COVID-19 can lead to Guillain-Barre Syndrome, many important questions remain. What are the chances that someone gets Guillain-Barre Syndrome during or following a COVID-19 infection? Does Guillain-Barre Syndrome happen more often in those who have been infected with COVID-19 compared to other types of infections, such as the flu?

The only way to get answers is through a prospective study where doctors perform systematic surveillance and collect data on a large group of patients. There are ongoing large research consortia hard at work to figure out answers to these questions.

Understanding the Association Between COVID-19 and Guillain-Barre Syndrome

While large research studies are underway, overall it appears that Guillain-Barre Syndrome is a rare but serious phenomenon possibly linked to COVID-19. Given that more than 10.7 million cases have been reported for COVID-19, there have been 10 reported cases of COVID-19 patients with Guillain-Barre Syndrome so far – only two reported cases in the U.S., five in Italy, two cases in Iran and one from Wuhan, China.

It is certainly possible that there are other cases that have not been reported. The Global Consortium Study of Neurological Dysfunctions in COVID-19 is actively underway to find out how often neurological problems like Guillain-Barre Syndrome is seen in hospitalized COVID-19 patients. Also, just because Guillain-Barre Syndrome occurs in a patient diagnosed with COVID-19, that does not imply that it was caused by the virus; this still may be a coincident occurrence. More research is needed to understand how the two events are related.

Due to the pandemic and infection-containment considerations, diagnostic tests, such as a nerve conduction study that used to be routine for patients with suspected Guillain-Barre Syndrome, are more difficult to do. In both U.S. cases, the initial diagnosis and treatment were all based on clinical examination by a neurological experts rather than any tests. Both patients survived but with significant residual weakness at the time these case reports came out, but that is not uncommon for Guillain-Barre Syndrome patients. The road to recovery may sometimes be long, but many patients can make a full recovery with time.

Though the reported cases of Guillain-Barre Syndrome so far all have severe symptoms, this is not uncommon in a pandemic situation where the less sick patients may stay home and not present for medical care for fear of being exposed to the virus. This, plus the limited COVID-19 testing capability across the U.S., may skew our current detection of Guillain-Barre Syndrome cases toward the sicker patients who have to go to a hospital. In general, the majority of Guillain-Barre Syndrome patients do recover, given enough time. We do not yet know whether this is true for COVID-19-related cases at this stage of the pandemic. We and colleagues around the world are working around the clock to find answers to these critical questions.

Sherry H-Y. Chou is an Associate Professor of Critical Care Medicine, Neurology, and Neurosurgery, University of Pittsburgh.

Aarti Sarwal is an Associate Professor, Neurology, Wake Forest University.

Neha S. Dangayach is an Assistant Professor of Neurology and Neurosurgery, Icahn School of Medicine at Mount Sinai.

Disclosure statement: Sherry H-Y. Chou receives funding from The University of Pittsburgh Clinical Translational Science Institute (CTSI), the National Institute of Health, and the University of Pittsburgh School of Medicine Dean's Faculty Advancement Award. Sherry H-Y. Chou is a member of Board of Directors for the Neurocritical Care Society. Neha S. Dangayach receives funding from the Bee Foundation, the Friedman Brain Institute, the Neurocritical Care Society, InCHIP-UConn Center for mHealth and Social Media Seed Grant. She is faculty for emcrit.org and for AiSinai. Aarti Sarwal does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Reposted with permission from The Conversation.


Nurses wear PPE prior to caring for a COVID-19 patient in the ICU at Sharp Grossmont Hospital on May 5, 2020 in La Mesa, California. Mario Tama / Getty Images

One of the initial reasons social distancing guidelines were put in place was to allow the healthcare system to adapt to a surge in patients since there was a critical shortage of beds, ventilators and personal protective equipment. In fact, masks that were designed for single-use were reused for an entire week in some hospitals.

Read More Show Less
Democratic presidential hopefuls Joe Biden and Senator Bernie Sanders greet each other with a safe elbow bump before the start of the Democratic Party 2020 presidential debate in a CNN Washington Bureau studio in Washington, DC on March 15, 2020. Mandel Ngan / AFP / Getty Images

By Jake Johnson

Unity Task Forces formed by presumptive Democratic presidential nominee Joe Biden and Sen. Bernie Sanders unveiled sweeping party platform recommendations Wednesday that—while falling short of progressive ambitions in a number of areas, from climate to healthcare—were applauded as important steps toward a bold and just policy agenda that matches the severity of the moment.

"We've moved the needle a lot, especially on environmental justice and upping Biden's ambition," said Sunrise Movement co-founder and executive director Varshini Prakash, a member of the Biden-Sanders Climate Task Force. "But there's still more work to do to push Democrats to act at the scale of the climate crisis."

The climate panel—co-chaired by Rep. Alexandria Ocasio-Cortez (D-N.Y.) and former Secretary of State John Kerry—recommended that the Democratic Party commit to "eliminating carbon pollution from power plants by 2035," massively expanding investments in clean energy sources, and "achieving net-zero greenhouse gas emissions for all new buildings by 2030."

In a series of tweets Wednesday night, Ocasio-Cortez—the lead sponsor of the House Green New Deal resolution—noted that the Climate Task Force "shaved 15 years off Biden's previous target for 100% clean energy."

"Of course, like in any collaborative effort, there are areas of negotiation and compromise," said the New York Democrat. "But I do believe that the Climate Task Force effort meaningfully and substantively improved Biden's positions."

 

The 110 pages of policy recommendations from the six eight-person Unity Task Forces on education, the economy, criminal justice, immigration, climate change, and healthcare are aimed at shaping negotiations over the 2020 Democratic platform at the party's convention next month.

Sanders said that while the "end result isn't what I or my supporters would've written alone, the task forces have created a good policy blueprint that will move this country in a much-needed progressive direction and substantially improve the lives of working families throughout our country."

"I look forward to working with Vice President Biden to help him win this campaign," the Vermont senator added, "and to move this country forward toward economic, racial, social, and environmental justice."

Biden, for his part, applauded the task forces "for helping build a bold, transformative platform for our party and for our country."

"I am deeply grateful to Bernie Sanders for working with us to unite our party and deliver real, lasting change for generations to come," said the former vice president.

On the life-or-death matter of reforming America's dysfunctional private health insurance system—a subject on which Sanders and Biden clashed repeatedly throughout the Democratic primary process—the Unity Task Force affirmed healthcare as "a right" but did not embrace Medicare for All, the signature policy plank of the Vermont senator's presidential bid.

Instead, the panel recommended building on the Affordable Care Act by establishing a public option, investing in community health centers, and lowering prescription drug costs by allowing the federal government to negotiate prices. The task force also endorsed making all Covid-19 testing, treatments, and potential vaccines free and expanding Medicaid for the duration of the pandemic.

"It has always been a crisis that tens of millions of Americans have no or inadequate health insurance—but in a pandemic, it's potentially catastrophic for public health," the task force wrote.

Dr. Abdul El-Sayed, a former Michigan gubernatorial candidate and Sanders-appointed member of the Healthcare Task Force, said that despite major disagreements, the panel "came to recommendations that will yield one of the most progressive Democratic campaign platforms in history—though we have further yet to go."

 

Observers and advocacy groups also applauded the Unity Task Forces for recommending the creation of a postal banking system, endorsing a ban on for-profit charter schools, ending the use of private prisons, and imposing a 100-day moratorium on deportations "while conducting a full-scale study on current practices to develop recommendations for transforming enforcement policies and practices at ICE and CBP."

Marisa Franco, director of immigrant rights group Mijente, said in a statement that "going into these task force negotiations, we knew we were going to have to push Biden past his comfort zone, both to reconcile with past offenses and to carve a new path forward."

"That is exactly what we did, unapologetically," said Franco, a member of the Immigration Task Force. "For years, Mijente, along with the broader immigrant rights movement, has fought to reshape the narrative around immigration towards racial justice and to focus these very demands. We expect Biden and the Democratic Party to implement them in their entirety."

"There is no going back," Franco added. "Not an inch, not a step. We must only move forward from here."

Reposted with permission from Common Dreams.

A grizzly bear sow with cub in Yellowstone National Park, Wyoming. Danita Delimont / Gallo Images / Getty Images Plus

Grizzly bears in Wyoming and Idaho won't be subject to a trophy hunt thanks to a federal court decision Wednesday upholding endangered species protections for these iconic animals.

Read More Show Less
Oregano oil is an extract that is not as strong as the essential oil, but appears to be useful both when consumed or applied to the skin. Peakpx / CC by 1.0

By Alexandra Rowles

Oregano is a fragrant herb that's best known as an ingredient in Italian food.

However, it can also be concentrated into an essential oil that's loaded with antioxidants and powerful compounds that have proven health benefits.

Read More Show Less
Brazilian President Jair Bolsonaro meets Ronaldo Caiado, governor of the state of Goiás on June 5, 2020. Palácio do Planalto / CC BY 2.0

Far-right Brazilian President Jair Bolsonaro, who has presided over the world's second worst coronavirus outbreak after the U.S., said Tuesday that he had tested positive for the virus.

Read More Show Less

Trending

Although natural gas produces fewer greenhouse gas emissions and other pollutants than coal or oil, it is a major contributor to climate change, an urgent global problem. Skitterphoto / PIxabay

By Emily Grubert

Natural gas is a versatile fossil fuel that accounts for about a third of U.S. energy use. Although it produces fewer greenhouse gas emissions and other pollutants than coal or oil, natural gas is a major contributor to climate change, an urgent global problem. Reducing emissions from the natural gas system is especially challenging because natural gas is used roughly equally for electricity, heating, and industrial applications.

Read More Show Less